Mabion S.A. (WSE:MAB)
Poland flag Poland · Delayed Price · Currency is PLN
7.75
-0.03 (-0.39%)
Sep 25, 2026, 10:14 AM CET

Mabion Revenue

Mabion had revenue of 3.26M PLN in the quarter ending June 30, 2026, with 0.06% growth. This brings the company's revenue in the last twelve months to 17.61M, up 56.67% year-over-year. In the year 2025, Mabion had annual revenue of 15.76M, down -77.17%.

Revenue (ttm)
17.61M
Revenue Growth
+56.67%
P/S Ratio
7.14
Revenue / Employee
87.20K
Employees
204
Market Cap
125.74M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202515.76M-53.26M-77.17%
Dec 31, 202469.02M-82.66M-54.50%
Dec 31, 2023151.68M-12.30M-7.50%
Dec 31, 2022163.98M107.11M188.33%
Dec 31, 202156.87M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 20155.47M3.81M229.28%
Dec 31, 20141.66M1.65M13,733.33%
Dec 31, 201312.00K-1.76M-99.32%
Dec 31, 20121.77M-1.97B-99.91%
Dec 31, 20111.97B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
BIOTON257.23M
Ryvu Therapeutics83.94M
Synthaverse42.19M
Molecure6.52M
Urteste2.50M
Captor Therapeutics Spolka Akcyjna2.01M
Pharmena1.46M
Poltreg240.00K
Revenue Rankings

Mabion News

More News